基于 DNA 超分子水凝胶的保护性 NK 细胞储库用于增强三阴性乳腺癌治疗
Protective NK Cell Reservoir Based on DNA Supramolecular Hydrogel for Enhanced Triple-Negative Breast Cancer Therapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon.
Potential activity of adiponectin-expressing regulatory T cells against triple-negative breast cancer cells through the cell-in-cell phenomenon.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
表达脂联素的 Treg 可能是用于三阴性乳腺癌过继性细胞治疗的候选细胞。
一群位于胸腺护士细胞复合体内的调节性T细胞(Treg)表达脂联素,并可在转基因小鼠中阻止乳腺癌发生。本研究考察表达脂联素的Treg是否可抑制三阴性乳腺癌;三阴性乳腺癌的定义为缺乏雌激素受体、孕激素受体和人表皮生长因子受体2。
从既往研究表征的实验性胸腺肿瘤模型中培养T淋巴细胞,并分选CD4阳性和CD25阳性细胞。该模型由胸腺护士细胞和丰富淋巴基质组成。研究检测分选细胞的FOXP3和脂联素免疫反应性,随后将其与三阴性乳腺癌MDA-MB-157和MDA-MB-231细胞共培养。
通过CD4阳性/CD25阳性分选获得表达脂联素的Treg,并通过细胞内细胞现象诱导三阴性乳腺癌细胞死亡。
表达脂联素的Treg可能成为三阴性乳腺癌过继性细胞治疗的候选细胞。
A population of regulatory T cells (Treg), which reside within thymic nurse cell complexes, express adiponectin and abrogate breast cancer development in transgenic mice. In this study, we examined whether adiponectin-expressing Treg could impair triple-negative breast cancer, which is defined by a lack of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor-2.
CD4- and CD25-positive cells were sorted from cultured T lymphocytes of a previously characterized experimental thymic tumor model composed of thymic nurse cells and abundant lymphoid stroma. These sorted cells were examined for FOXP3 and adiponectin immunoreactivity and subsequently exposed to triple-negative breast cancer MDA-MB-157 and -231 cells.
Adiponectin-expressing Treg were obtained by CD4- and CD25-positive sorting and cell death was induced in triple-negative breast cancer cells through the cell-in-cell phenomenon.
Adiponectin-expressing Treg may be candidates for adoptive cell therapy against triple-negative breast cancer.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。